Koba K, Imamura J, Akashoshi A, Kohno-Murase J, Nishizono S, Iwabuchi M, Tanaka K, Sugano M (2007) Genetically modified rapeseed oil containing cis-9, trans-11, cis-13-octadecatrienoic acid affects body fat mass and lipid metabolism in mice. Clin Nutr 27(5):764–772Īrao K, Yotsumoto H, Han S, Nagao K, Yanagita T (2004) The 9cis,11trans,13cis isomer of conjugated linolenic acid reduces apolipoprotein B100 secretion and triacylglycerol synthesis in HepG2 cells. Hontecillas R, Diguardo M, Duran E, Orpi M, Bassaganya-Riera J (2008) Catalpic acid decreases abdominal fat deposition, improves glucose homeostasis and upregulates PPAR alpha expression in adipose tissue.
CIS 9 TRANS 11 ACTIVATOR
doi: 10.2903/j.efsa.2010.1794Ĭhuang C, Hsu C, Chao C, Wein Y, Kuo Y, Huang C (2006) Fractionation and identification of 9c,11t,13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.). Am J Clin Nutr 85(5):1203–1211ĮFSA Panel on Dietetic Products NaAN (2010) Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. Whigham L, Watras A, Schoeller D (2007) Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Salas-Salvado J, Marquez-Sandoval F, Bullo M (2006) Conjugated linoleic acid intake in humans: a systematic review focusing on its effect on body composition, glucose, and lipid metabolism. Larsen TM, Toubro S, Astrup A (2003) Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. Terpstra AH (2004) Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature. Navarro V, Fernández-Quintela A, Churruca I, Portillo M (2006) The body fat-lowering effect of conjugated linoleic acid: a comparison between animal and human studies. Martin JC, Valeille K (2002) Conjugated linoleic acids: all the same or to everyone its own function? Reprod Nutr Dev 42(6):525–536ĭomeneghini C, Di Giancamillo A, Corino C (2006) Conjugated linoleic acids (CLAs) and white adipose tissue: how both in vitro and in vivo studies tell the story of a relationship. Best Pract Res Clin Endocrinol Metab 20(4):647–664Įvans M, Brown J, McIntosh M (2002) Isomer-specific effects of conjugated linoleic acid (CLA) on adiposity and lipid metabolism.
Mutch D, Clément K (2006) Genetics of human obesity. The hypothesis of an anti-obesity action of the analyzed CLNA mixture, based on increased lipid mobilization in adipose tissue, can be proposed. The other genes analyzed remained unchanged. The lowest dose (10 μM) increased HSL expression and the highest dose (100 μM) increased ATGL gene expression. Decreased triacylglycerol was found in treated adipocytes. The mixture activated PPRE in cells with PPARα receptor over-expression, but not those with PPARγ over-expression. The expression of several enzymes and transcriptional factors involved in the main metabolic pathways that control triacylglycerol accumulation in adipocytes was assessed by real time RT-PCR in 3T3-L1 adipocytes treated for 20 h with the CLNA mixture. Luciferase transactivation assay was used to analyze whether the CLNA mixture activated PPARs. Secondly, we aimed to analyze the effects of this mixture on triacylglycerol accumulation in 3T3-L1 mature adipocytes. The aim of the present work was to assess the potential agonism on PPARα and PPARγ of a conjugated linolenic acid (CLNA) isomer mixture, consisting of two CLNA isomers ( cis-9, trans-11, cis-15 and cis-9, trans-13, cis-15). Scientific research is constantly working to find new molecules that are effective in preventing excessive accumulation of body fat.